Resistance of neuronal nitrix oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity

Journal of Pharmacology and Experimental Therapeutics

Volumn 284, Issue 3, 1998, Pages 1040-1047

  Itzhak, Yossef ^a   Gandia, Carlos ^a   Huang, Paul L ^b   Ali, Syed F ^c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE; HOMOVANILLIC ACID; METHAMPHETAMINE; NITRIC OXIDE SYNTHASE; CARRIER PROTEIN; DOPAMINE TRANSPORTER; GLUTAMATE RECEPTOR; MEMBRANE PROTEIN; NERVE PROTEIN; SLC6A3 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; ENZYME DEFICIENCY; GENE MUTATION; HETEROZYGOSITY; HOMOZYGOSITY; LOCOMOTION; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; ANIMAL; ANIMAL BEHAVIOR; BINDING SITE; BODY TEMPERATURE; C57BL MOUSE; CHEMISTRY; DRUG EFFECT; GENETICS; METABOLISM; MOTOR ACTIVITY; MOUSE MUTANT; PHYSIOLOGY;

ANIMALS; BEHAVIOR, ANIMAL; BINDING SITES; BODY TEMPERATURE; CARRIER PROTEINS; CORPUS STRIATUM; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; METHAMPHETAMINE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; NERVE TISSUE PROTEINS; NITRIC OXIDE SYNTHASE; RECEPTORS, GLUTAMATE;

EID: 0031594132     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Abekawa T, Ohmori T and Koyama T (1996) Effect of nitric oxide synthesis inhibition on methamphetamine-induced dopaminergic and serotoninergic neurotoxicity in the rat brain. J Neural Transm 103:671-680.
2. Ali SF, Newport GD, Holson RR, Slikker W Jr and Bowyer JF (1994) Low environmental temperature or pharmacologic agents that produce hypothermia decrease methamphetamine neurotoxicity in mice. Brain Res 658:33-38.
3. Beckman JS, Beckman TW, Chen J, Marshall PM and Freeman BA (1990) Apparent hydroxy radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87:1621-1624.
4. Bowyer JF, Clausing P, Gough B, Slikker W Jr and Holson RR (1995) Nitric oxide regulation of methamphetamine-induced dopamine release in caudate/putamen. Brain Res 699:62-70.
5. Bowyer JF, Tank AW, Newport GD, Slikker W Jr, Ali SF and Holson RR (1992) The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum. J Pharmacol Exp Ther 260:817-824.
6. Cadet JL, Ali SF, Rothman RB and Epstein C (1995) Neurotoxicity, drugs of abuse and CuZn-superoxide dismutase transgenic mice. Mol Neurobiol 11:145-155.
7. Carlsson M and Carlsson A (1990) Interaction between glutamatergic and monoaminergic systems within the basal ganglia: Implications for schizophrenia and Parkinson's disease. Trends Neurosci 13:272-276.
8. Dawson VL, Dawson TM, Bartley DA, Uhl GR and Snyder SH (1993) Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J Neurochem 13: 2651-2661.
9. De Vito MJ and Wagner GC (1989) Methamphetamine-induced neuronal damage: A possible role for free radicals. Neuropharmacology 28:1145-1150.
10. Di Monte DA, Royland JE, Jakowec MW and Langston JW (1996) Role of nitric oxide in methamphetamine neurotoxicity: Protection by 7-nitroindazole, an inhibitor of neuronal nitric oxide synthase. J Neurochem 67:2443-2450.
11. Farfel GM, Vosmer GL and Seiden LS (1992) The N-methyl-D-aspartate antagonist MK-801 protects against serotonin depletion induced by methamphetamine, 3,4-methylenedioxymethamphetamine and p-chloroamphetamine. Brain Res 595: 121-127.
12. Fuller RW and Hemrick-Luecke S (1980) Long-lasting depletion of striatal dopamine by a single injection of amphetamine in iprindole-treated rats. Science (Wash DC) 209:305-307.
13. Garthwaite J (1991) Glutamate, nitric oxide, and cell-cell signalling in the nervous system. Trends Neurosci 14:60-67.
14. Gibb JW, Johnson M and Hanson GR (1990) Neurochemical basis of neurotoxicity. Neurotoxicology 11:317-321.
15. Giros B, Jaber M, Jones SR, Wightman RM and Caron MG (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature (Lond) 379:606-612.
16. Hantraye P, Brouillet E, Ferrante R. Palfi S, Dolan R, Matthews RT and Beal MF (1996) Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons. Nature Med 2:1017-102.
17. Huang PL, Dawson TM, Bredt DS, Snyder SH and Fishman MC (1993) Targeted disruption of neuronal nitric oxide synthase gene. Cell 75:1273-1286.
18. Huang Z, Huang PL, Panahian N, Dalkara T, Fishman MC and Moskowitz MA (1994) Effect of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science (Wash DC) 265:1883-1885.
19. Itzhak Y (1997) Modulation of cocaine-and methamphetamine-induced behavioral sensitization by inhibition of brain nitric oxide synthase. J Pharmacol Exp Ther 282:521-527.
20. Itzhak Y and Ali SF (1996) The neuronal nitric oxide synthase inhibitor, 7-nitroindazole, protects against methamphetamine-induced neurotoxicity in vivo. J Neurochem 67:1770-1773.
21. Kalivas PW and Duffy P (1993) Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Cocaine administration in rats. J Neurosci 13: 266-275.
22. Kalivas PW and Stewart J (1991) Dopamine transmission in the initiation and expression of drug-and stress-induced sensitization of motor activity. Brain Res Rev 16:223-244.
23. Karler R, Chaudhry IA, Calder LD and Turkanis SA (1990) Amphetamine behavioral sensitization and excitatory amino acids. Brain Res 537:76-82.
24. Kogan FJ, Nichols WK and Gibb JW (1976) Influence of methamphetamine on nigra and striatal tyrosine hydroxylase activity and on striatal dopamine levels. Eur J Pharmacol 36:363-371.
25. Kuperman DI, Freyladenhoven TF, Schmued L and Ali SF (1997) Methamphetamine-induced hyperthermia in mice: Examination of dopamine depletion and heat shock protein induction. Brain Res 771:221-227.
26. 3H]dopamine release from striatal slices. J Neurosci Res 35:192-198.
27. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ (1951) Protein measurements with Folin phenol reagent. J Biol Chem 193:265-275.
28. Miller DB and O'Callagahan JP (1994) Environmental-, drug-and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse. J Pharmacol Exp Ther 270:752-760.
29. Montague PR, Gancayco CD, Winn MJ, Marchase RB and Fridlander MJ (1994) Role of NO production in NMDA receptor-mediated neurotransmitter release in cerebral cortex. Science (Wash DC) 263:973-977.
30. Nash JF and Yamamoto BK (1992) Methamphetamine neurotoxicity and striatal glutamate release: Comparison to 3,4-methylenedioxymethamphetamine. Brain Res 581:237-243.
31. Przedborski S, Jackson-Lewis V, Yokoyama R, Shibata T, Dawson VL and Dawson TM (1996) Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc Natl Acad Sci USA 93:4565-4571.
32. Robinson TE and Becker JB (1986) Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis. Brain Res 396:157-198.
33. Robinson TE and Berridge KC (1993) The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Res Rev 18:247-291.
34. Robinson TE, Yew J, Paulson PE and Camp DM (1990) The long-term effects of neurotoxic doses of methamphetamine on the extracellular concentration of dopamine measured with microdialysis in striatum. Neurosci Lett 110:193-198.
35. Schulz BJ, Huang PL, Matthews RT, Passov D, Fishman MC and Beal MF (1996) Striatal malonate lesions are attenuated in neuronal nitric oxide synthase knockout mice. J Neurochem 67:430-433.
36. Schulz JB, Matthews RT, Muqit MMK, Browne SE and Beal MF (1995) Inhibition of neuronal nitric oxide synthase protects against MPTP-induced neurotoxicity in mice. J Neurochem 64:936-939.
37. Segal DS and Kuczenski R (1992) In vivo microdialysis reveals a diminished amphetamine-induced DA response corresponding to behavioral sensitization produced by repeated amphetamine pretreatment. Brain Res 57:330-337.
38. Segal DS and Kuczenski R (1997) An escalating dose "binge" model of amphetamine psychosis: Behavioral and neurochemical characteristics. J Neurosci 17:2551-2566.
39. Sheng P, Cerruit C, Ali SF and Cadet JL (1996) Nitric oxide is a mediator of methamphetamine-induced neurotoxicity: In vitro evidence from primary cultures of mesencephalic cells. Ann NY Acad Sci 801:174-186.
40. Shibata M, Araki N, Ohta K, Hamada J, Shimazu K and Fukuuchi Y (1996) Nitric oxide regulates NMDA-induced dopamine release in the striatum. NeuroReport 7:605-608.
41. Silva MT, Rose S, Hindmarsh JG, Aislaitner G, Gorrod JW, Moore PK, Jenner P and Marsden CD (1995) Increased striatal dopamine efflux in vivo following inhibition of cerebral nitric oxide synthase by novel monosodium salt of 7-nitroindazole. Br J Pharmacol 114:257-258.
42. Snyder SH (1992) Nitric oxide: First in a new class of neurotransmitters? Science (Wash DC) 257:494-496.
43. Sonsalla PK, Nicklas WJ and Heikkila RE (1989) Role of excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity. Science (Wash DC) 243:398-400.
44. Strasser A, McCarron RM, Ishii H, Stanimirovic D and Spatz M (1994) L-Arginine induces dopamine release from the striatum in vivo. NeuroReport 5:2298-2300.
45. Wagner GC, Ricaurte GA, Seiden LS, Schuster CR, Miller RJ and Westley J (1980) Long-lasting depletion of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Res 181:151-160.
46. Weihmuller FB, O'Dell SJ and Marshall SJ (1992) MK-801 protects against methamphetamine-induced striatal dopamine terminal injury and is associated with attenuated dopamine overflow. Synapse 11:155-163.
47. White FJ and Wolf ME (1991) Psychomotor stimulants, in The Biological Bases of Drug Tolerance and Dependence (Pratt J ed) pp 153-197, Academic Press, London.
48. Wilson JM, Kalasinsky KS, Levey AI, Bergeron C, Reiber G, Anthony RM, Schmunk GA, Shannak K, Haycock JW and Kish SJ (1996) Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nature Med 2:699-703.
49. Xue C-J, Ng JP, Li Y and Wolf ME (1996) Acute and repeated amphetamine administration: Effects on extracellular glutamate, aspartate, and serine levels in rat ventral tegmental area and nucleus accumbens. J Neurochem 67:352-363.
50. Zhang J, Dawson VL, Dawson TM and Snyder SH (1994) Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science (Wash DC) 263:687-689.
51. Zhu X-Z and Luo L-G (1992) Effect of nitroprusside (nitric oxide) on endogenous dopamine release from rat striatal slices. J Neurochem 59:932-935.